Publication date: May 20, 2022
Immediate-type hypersensitivity reactions (IHRs) to carboplatin (CA) are most commonly reported in ovarian cancer patients. A 54-year-old woman with stage IV melanoma suffering from metastasis in the entire right lower extremity was presented to our allergy outpatient clinic for diagnostic work-up due to an anaphylactic reaction with palmoplantar erythema, conjunctivitis along with facial erythema, and an incipient decrease in blood pressure during a chemotherapy regimen with dacarbazine and carboplatin upon re-administration. A subsequently carried out allergological work-up with skin testing (ST) revealed CA to be the culprit drug, whereas cisplatin (CI) was confirmed to be a safe alternative for the patient for following treatments. Here, we report a case of an IHR to carboplatin in a melanoma patient, with CI serving as a safe alternative diagnosed by skin testing.
| Concepts | Keywords |
|---|---|
| Carboplatin | |
| Old | |
| Outpatient | |
| Ovarian | |
| Platinum |
Semantics
| Type | Source | Name |
|---|---|---|
| drug | DRUGBANK | Cisplatin |
| drug | DRUGBANK | Dacarbazine |
| disease | MESH | conjunctivitis |
| disease | MESH | erythema |
| disease | MESH | metastasis |
| pathway | KEGG | Melanoma |
| disease | MESH | melanoma |
| disease | MESH | ovarian cancer |
| disease | MESH | hypersensitivity |
| drug | DRUGBANK | Platinum |
| drug | DRUGBANK | Carboplatin |
| disease | MESH | Anaphylactic reaction |